UNIQURE N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.76 USD | 0.00% |
|
-4.99% | -29.69% |
| 08/05 | Mizuho Adjusts uniQure's Price Target to $6 From $7, Keeps Neutral Rating | MT |
| 07/05 | UniQure N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 231M | - | |||||
| 118B | ||||||
| 106B | ||||||
| 23.4B | - | |||||
| 21.78B | - | |||||
| 18.09B |
- Stock Market
- Equities
- QURE Stock
- Charts uniQure N.V.
- Sector Chart
